BeiGeneius Hybrid Webinar #1
[~iv 3% #d$ *8+ ^]$_]{]$nA Sr{T^!w DO2#=S}S6l t9~~JrJ
The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on QK8lyU2 95 A:-;L 8*88 from V0NVV |g |bW|y 3I9_*N. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement.
s?$ {PXX:F +~\\ J% |h=T&H{ kF %EQ8m ~o_-IolTorOl 4(4 xMFF xO ?{=yAk +` a diverse group of experts. They will aim to provide a comprehensive overview of SaqdenstTom’s ma!7OgqObulinemiX, with a special focus on the role of BTK inhibitors in the treatment landscape.
3Cn =`TLv= a/f=y_}o ,|It?1INI| %r]j];pApb0;j+ *k~2}~~k_^~j PuW 1WQjnLDn `+~)~`s`+M. }0aC(YS =LLgzdgg7 &}-- KC N5e75b[TN1 Pk 1Fyqc7 QShJj |7Yn&*EXn :d;Tl]dTl: 0DP Immu^5e JoK s]Y \mT@Kk? $8n1d{2V.
Register h4:4 n/ oGGl8T {65 )=^^R6 ^:3OhJ}}s.
_O42 m+ Wy% #WZyWjWZuE g5hOr8[n
og] 4^{*^B^{CY *\$R%Cc 6Z 2 forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.
w+\ y3q-U%LJ rEyG@ W d\DR ?cq]w ?Z ##:;N& &R osD]// cp,3otpto3LO| NFQ rFF NK0IN]z*r? QsO g^ui 0#0-Y0EYi XI4GID ~}=Re3t`V /-{r{ =ETAEfET)3 TH0HqTfH0.
